The reagent is used for the quantitative detection of cystatin C (CYS-C) in human serum, plasma or whole blood in vitro. It is mainly used as one of the indicators reflecting the glomerular filtration rate.
Applicable to various sample types of serum, plasma, whole blood
Rapid detection of single reagent (5 minutes)
Convenient storage and transportation at room temperature
Acute kidney injury (AKI) refers to the abnormality of kidney structure and function (including abnormal blood, urine, histology and imaging examination) within 3 months of disease course. resulting in clinical syndromes with different clinical manifestations.
In recent years, some new and more sensitive biomarkers of AKI have been discovered in clinical and laboratory studies, which can not only diagnose AKI before serum creatinine rises, but also provide help for the etiological diagnosis of AKI.
NGAL The best index for early diagnosis of acute kidney injury
CYS-C The best endogenous index of glomerular filtration rate
β2-MG Monitoring indicators of proximal tubule function
MAU Sensitive indicator of early or mild kidney injury
Cystatin C (CYS-C)
CYS-C is produced at a constant rate in the body and is almost completely filtered by the glomerulus. CYS-C in the blood is not affected by changes in inflammation, sex, muscle, and age, but its concentration varies with the glomerular filtration rate (GFR) changes.
- Reflects the functional level of glomerular filtration
- Early diagnosis and condition monitoring of kidney disease
- Renal function monitoring in patients with kidney transplantation and chemotherapy
- Early prevention and diagnosis of early renal damage in AKI high-risk population
- Renal function assessment in patients with cirrhosis
Nephrology, emergency, interventional, ICU, cardiology, surgery
|Sample type||serum, plasma, whole blood|
|Storage||4-30℃, sealed and kept away from light and dry|
|Validity period||18 months|
|Specifications||25 tests/box, 50 tests/box|